SCNI
Scinai Immunotherapeutics
SCNI
SCNI
11 hedge funds and large institutions have $2.51M invested in Scinai Immunotherapeutics in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
$140K |
2 |
UBS Group
Zurich,
Switzerland
|
$25K |
Top Sellers
1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$15K |
2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
$141K |